Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.

Autor:	Ito, Genta1 (AUTHOR), Kawakami, Kazuyoshi2 (AUTHOR), Aoyama, Takeshi2 (AUTHOR), Yokokawa, Takashi2 (AUTHOR), Nakamura, Masashi2 (AUTHOR), Ozaka, Masato3 (AUTHOR), Sasahira, Naoki3 (AUTHOR), Hashiguchi, Masayuki1 (AUTHOR), Kizaki, Hayato1 (AUTHOR), Hama, Toshihiro2 (AUTHOR), Hori, Satoko1 (AUTHOR) hori-st@pha.keio.ac.jp
Zdroj:	PLoS ONE. 7/14/2021, Vol. 16 Issue 7, p1-11. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu